These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 12496694)
1. Serous tumors of the ovary (borderline tumors and carcinomas) with and without micropapillary features. Prat J Int J Gynecol Pathol; 2003 Jan; 22(1):25-8. PubMed ID: 12496694 [No Abstract] [Full Text] [Related]
2. Loss of p16INK4A expression in low-grade ovarian serous carcinomas. Schlosshauer PW; Deligdisch L; Penault-Llorca F; Fatemi D; Qiao R; Yao S; Pearl M; Yang Z; Sheng T; Dong J Int J Gynecol Pathol; 2011 Jan; 30(1):22-9. PubMed ID: 21131838 [TBL] [Abstract][Full Text] [Related]
3. The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis. Dehari R; Kurman RJ; Logani S; Shih IeM Am J Surg Pathol; 2007 Jul; 31(7):1007-12. PubMed ID: 17592266 [TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of K-ras segregates ovarian serous carcinomas into two types: invasive MPSC (low-grade tumor) and conventional serous carcinoma (high-grade tumor). Singer G; Shih IeM; Truskinovsky A; Umudum H; Kurman RJ Int J Gynecol Pathol; 2003 Jan; 22(1):37-41. PubMed ID: 12496696 [TBL] [Abstract][Full Text] [Related]
5. Low-grade serous neoplasms of the ovary with transformation to high-grade carcinomas: a report of 3 cases. Garg K; Park KJ; Soslow RA Int J Gynecol Pathol; 2012 Sep; 31(5):423-8. PubMed ID: 22833081 [TBL] [Abstract][Full Text] [Related]
6. Low-grade serous tumors of ovary. Bell DA Int J Gynecol Pathol; 2014 Jul; 33(4):348-56. PubMed ID: 24901394 [TBL] [Abstract][Full Text] [Related]
7. The continuum of serous tumors of low malignant potential and low-grade serous carcinomas of the ovary. Wong KK; Gershenson D Dis Markers; 2007; 23(5-6):377-87. PubMed ID: 18057521 [TBL] [Abstract][Full Text] [Related]
8. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas]. Shao HL; Shen DH; Xue WC; Li Y; Yu YZ Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760 [TBL] [Abstract][Full Text] [Related]
9. Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion. Prat J; De Nictolis M Am J Surg Pathol; 2002 Sep; 26(9):1111-28. PubMed ID: 12218568 [TBL] [Abstract][Full Text] [Related]
10. Micropapillary serous carcinoma of the ovary has distinct patterns of chromosomal imbalances by comparative genomic hybridization compared with atypical proliferative serous tumors and serous carcinomas. Staebler A; Heselmeyer-Haddad K; Bell K; Riopel M; Perlman E; Ried T; Kurman RJ Hum Pathol; 2002 Jan; 33(1):47-59. PubMed ID: 11823973 [TBL] [Abstract][Full Text] [Related]
11. [Clinical behavior of serous and mucinous borderline tumors of the ovary with diploid DNA stem line. Follow-up studies after organ preserving and non-organ preserving therapy]. Mecke H; Börner-Klaussner B; Grosse G; Nadjari B; Hauptmann S Zentralbl Gynakol; 2000; 122(5):274-9. PubMed ID: 10857214 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas. Shappell HW; Riopel MA; Smith Sehdev AE; Ronnett BM; Kurman RJ Am J Surg Pathol; 2002 Dec; 26(12):1529-41. PubMed ID: 12459620 [TBL] [Abstract][Full Text] [Related]
13. Cell polarity reversal in ovarian low-grade serous carcinomas and micropapillary serous borderline tumours: immunohistochemical observations. Hui Y; Ou JJ; Sung CJ; Lawrence WD; Quddus MR Histopathology; 2016 Nov; 69(5):892-894. PubMed ID: 27271798 [No Abstract] [Full Text] [Related]
14. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants. Mayr D; Hirschmann A; Löhrs U; Diebold J Gynecol Oncol; 2006 Dec; 103(3):883-7. PubMed ID: 16806438 [TBL] [Abstract][Full Text] [Related]
15. [Diagnostic difficulties in serous "borderline" tumors of the ovary]. Vereczkey I; Tóth E; Orosz Z Magy Onkol; 2009 Mar; 53(1):23-31. PubMed ID: 19318323 [TBL] [Abstract][Full Text] [Related]
16. Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation. Choi YL; Kim J; Kwon MJ; Choi JS; Kim TJ; Bae DS; Koh SS; In YH; Park YW; Kim SH; Ahn G; Shin YK Histol Histopathol; 2007 Nov; 22(11):1185-95. PubMed ID: 17647191 [TBL] [Abstract][Full Text] [Related]
17. Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver. Emmanuel C; Chiew YE; George J; Etemadmoghadam D; Anglesio MS; Sharma R; Russell P; Kennedy C; Fereday S; Hung J; Galletta L; Hogg R; Wain GV; Brand A; Balleine R; MacConaill L; Palescandolo E; Hunter SM; Campbell I; Dobrovic A; Wong SQ; Do H; Clarke CL; Harnett PR; Bowtell DD; deFazio A; Clin Cancer Res; 2014 Dec; 20(24):6618-30. PubMed ID: 25316818 [TBL] [Abstract][Full Text] [Related]
18. Borderline epithelial tumors of the ovary. Hart WR Mod Pathol; 2005 Feb; 18 Suppl 2():S33-50. PubMed ID: 15761465 [TBL] [Abstract][Full Text] [Related]
19. High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma. Cui X; Li L; Yan G; Meng K; Lin Z; Nan Y; Jin G; Li C BMC Cancer; 2015 Apr; 15():244. PubMed ID: 25885439 [TBL] [Abstract][Full Text] [Related]
20. Bilateral micropapillary serous carcinoma of the ovary: a case report. Gupta R; Singh S; Nigam S Arch Gynecol Obstet; 2007 May; 275(5):401-4. PubMed ID: 17031658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]